DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,036 filers reported holding DANAHER CORPORATION in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,656,811 | -6.9% | 6,678 | -9.9% | 0.06% | -3.2% |
| Q2 2023 | $1,779,120 | -10.1% | 7,413 | -5.6% | 0.06% | -12.7% |
| Q1 2023 | $1,979,522 | -8.7% | 7,854 | -3.8% | 0.07% | -11.2% |
| Q4 2022 | $2,167,419 | -18.9% | 8,166 | -21.2% | 0.08% | -25.2% |
| Q3 2022 | $2,674,000 | -19.6% | 10,360 | -21.1% | 0.11% | -9.3% |
| Q2 2022 | $3,327,000 | -54.7% | 13,124 | -47.6% | 0.12% | -70.6% |
| Q1 2022 | $7,341,000 | -29.6% | 25,028 | -21.0% | 0.40% | +27.6% |
| Q4 2021 | $10,421,000 | +10.0% | 31,677 | +1.8% | 0.32% | +1.9% |
| Q3 2021 | $9,472,000 | +1301.2% | 31,117 | +1133.3% | 0.31% | +758.3% |
| Q2 2021 | $676,000 | -2.3% | 2,523 | -18.0% | 0.04% | -10.0% |
| Q1 2021 | $692,000 | -3.5% | 3,077 | -4.8% | 0.04% | -16.7% |
| Q4 2020 | $717,000 | -6.9% | 3,232 | -9.7% | 0.05% | -17.2% |
| Q3 2020 | $770,000 | +23.0% | 3,578 | +1.1% | 0.06% | +18.4% |
| Q2 2020 | $626,000 | +30.1% | 3,539 | +1.5% | 0.05% | +8.9% |
| Q1 2020 | $481,000 | -14.4% | 3,485 | -5.0% | 0.04% | +9.8% |
| Q4 2019 | $562,000 | +6.2% | 3,670 | 0.0% | 0.04% | 0.0% |
| Q3 2019 | $529,000 | +1.0% | 3,670 | 0.0% | 0.04% | +2.5% |
| Q2 2019 | $524,000 | +8.3% | 3,670 | 0.0% | 0.04% | +2.6% |
| Q1 2019 | $484,000 | +12.8% | 3,670 | -12.0% | 0.04% | +2.6% |
| Q4 2018 | $429,000 | -11.9% | 4,170 | -7.0% | 0.04% | 0.0% |
| Q3 2018 | $487,000 | +10.4% | 4,484 | 0.0% | 0.04% | +2.7% |
| Q2 2018 | $441,000 | +7.8% | 4,484 | +7.7% | 0.04% | -7.5% |
| Q1 2018 | $409,000 | +6.0% | 4,164 | +2.5% | 0.04% | +8.1% |
| Q4 2017 | $386,000 | +27.0% | 4,064 | +14.9% | 0.04% | +19.4% |
| Q3 2017 | $304,000 | +4.8% | 3,536 | 0.0% | 0.03% | -3.1% |
| Q2 2017 | $290,000 | -43.2% | 3,536 | -41.4% | 0.03% | -44.8% |
| Q1 2017 | $511,000 | +110.3% | 6,036 | +93.0% | 0.06% | +87.1% |
| Q4 2016 | $243,000 | 0.0% | 3,128 | 0.0% | 0.03% | 0.0% |
| Q3 2016 | $243,000 | -85.4% | 3,128 | -81.0% | 0.03% | -86.2% |
| Q2 2016 | $1,661,000 | -61.9% | 16,463 | -64.0% | 0.22% | -53.7% |
| Q1 2016 | $4,359,000 | +11.3% | 45,723 | +8.4% | 0.49% | -30.1% |
| Q4 2015 | $3,915,000 | +6.0% | 42,161 | -2.7% | 0.70% | +21.9% |
| Q3 2015 | $3,693,000 | -1.9% | 43,351 | -1.4% | 0.57% | +4.4% |
| Q2 2015 | $3,764,000 | +5.4% | 43,985 | +4.7% | 0.55% | +5.6% |
| Q1 2015 | $3,572,000 | +4.8% | 42,022 | +5.7% | 0.52% | -1.1% |
| Q4 2014 | $3,409,000 | +17.8% | 39,745 | +4.3% | 0.52% | +15.7% |
| Q3 2014 | $2,894,000 | -0.3% | 38,106 | +2.5% | 0.45% | +7.6% |
| Q2 2014 | $2,904,000 | +7.4% | 37,187 | +3.2% | 0.42% | +10.8% |
| Q1 2014 | $2,705,000 | +13.3% | 36,050 | +10.4% | 0.38% | +6.2% |
| Q4 2013 | $2,388,000 | +8.5% | 32,646 | +2.8% | 0.36% | +0.8% |
| Q3 2013 | $2,200,000 | +1095.7% | 31,743 | +991.6% | 0.35% | +276.6% |
| Q2 2013 | $184,000 | +21.1% | 2,908 | +18.7% | 0.09% | +10.6% |
| Q1 2013 | $152,000 | +9.4% | 2,449 | -1.4% | 0.08% | -14.1% |
| Q4 2012 | $139,000 | -10.3% | 2,485 | -11.7% | 0.10% | -20.8% |
| Q3 2012 | $155,000 | -39.9% | 2,813 | -38.4% | 0.12% | -38.7% |
| Q2 2012 | $258,000 | -4.1% | 4,565 | -0.1% | 0.20% | -8.5% |
| Q1 2012 | $269,000 | – | 4,571 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |